Business Description
ViroGates A/S
ISIN : DK0061030574
Compare
Compare
Traded in other countries / regions
VIRO.Denmark IPO Date
2018-06-26Description
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.31 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | -0.41 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 3.55 | |||||
Beneish M-Score | -4.06 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.3 | |||||
3-Year EBITDA Growth Rate | 8.2 | |||||
3-Year EPS without NRI Growth Rate | 9.6 | |||||
3-Year FCF Growth Rate | 2.2 | |||||
3-Year Book Growth Rate | -30.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.09 | |||||
9-Day RSI | 33.05 | |||||
14-Day RSI | 38.43 | |||||
6-1 Month Momentum % | -6.9 | |||||
12-1 Month Momentum % | -58.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.64 | |||||
Quick Ratio | 10.45 | |||||
Cash Ratio | 8.34 | |||||
Days Inventory | 1206.65 | |||||
Days Sales Outstanding | 67.05 | |||||
Days Payable | 236.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.8 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 82.41 | |||||
Operating Margin % | -174.87 | |||||
Net Margin % | -171.56 | |||||
FCF Margin % | -169.01 | |||||
ROE % | -105.7 | |||||
ROA % | -71.39 | |||||
ROIC % | -171.23 | |||||
ROC (Joel Greenblatt) % | -226.95 | |||||
ROCE % | -79.51 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.12 | |||||
PB Ratio | 2.91 | |||||
Price-to-Tangible-Book | 2.91 | |||||
EV-to-EBIT | -2.48 | |||||
EV-to-EBITDA | -2.48 | |||||
EV-to-Revenue | 4.31 | |||||
EV-to-FCF | -2.78 | |||||
Price-to-Net-Current-Asset-Value | 2.95 | |||||
Price-to-Net-Cash | 7.12 | |||||
Earnings Yield (Greenblatt) % | -40.39 | |||||
FCF Yield % | -32.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ViroGates A/S Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 7.432 | ||
EPS (TTM) (kr) | -2.417 | ||
Beta | 0.61 | ||
Volatility % | 78.04 | ||
14-Day RSI | 38.43 | ||
14-Day ATR (kr) | 0.562705 | ||
20-Day SMA (kr) | 6.6975 | ||
12-1 Month Momentum % | -58.23 | ||
52-Week Range (kr) | 4.98 - 19.508433 | ||
Shares Outstanding (Mil) | 6.44 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ViroGates A/S Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ViroGates A/S Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
ViroGates A/S Frequently Asked Questions
What is ViroGates A/S(OCSE:VIRO)'s stock price today?
The current price of OCSE:VIRO is kr6.05. The 52 week high of OCSE:VIRO is kr19.51 and 52 week low is kr4.98.
When is next earnings date of ViroGates A/S(OCSE:VIRO)?
The next earnings date of ViroGates A/S(OCSE:VIRO) is 2024-08-15.
Does ViroGates A/S(OCSE:VIRO) pay dividends? If so, how much?
ViroGates A/S(OCSE:VIRO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |